109 related articles for article (PubMed ID: 8164367)
1. [Pharmacological mechanism of action and development of anti-steroid hormones].
Oh-ishi S
Nihon Rinsho; 1994 Mar; 52(3):679-84. PubMed ID: 8164367
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of antisteroid hormones at the receptor level.
Baulieu EE
Kidney Int Suppl; 1988 Oct; 26():S2-7. PubMed ID: 3059030
[No Abstract] [Full Text] [Related]
3. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
4. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F
Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052
[TBL] [Abstract][Full Text] [Related]
5. Hormone agonists and antagonists in the treatment of hormone sensitive breast and prostate cancer.
Nicholson RI; Walker KJ; Davies P
Cancer Surv; 1986; 5(3):463-86. PubMed ID: 3555778
[No Abstract] [Full Text] [Related]
6. Castration and antisteroid treatment impair vocal learning in male zebra finches.
Bottjer SW; Hewer SJ
J Neurobiol; 1992 Jun; 23(4):337-53. PubMed ID: 1634883
[TBL] [Abstract][Full Text] [Related]
7. Hormonal therapy of prostate cancer.
Labrie F
Prog Brain Res; 2010; 182():321-41. PubMed ID: 20541672
[TBL] [Abstract][Full Text] [Related]
8. Dopamine agonists, anti-progestins, anti-androgens, long-term-release GnRH agonists and anti-estrogens in canine reproduction: a review.
Gobello C
Theriogenology; 2006 Oct; 66(6-7):1560-7. PubMed ID: 16542717
[TBL] [Abstract][Full Text] [Related]
9. Definition of the cellular mechanisms which distinguish between hormone and antihormone activated steroid receptors.
McDonnell DP; Clemm DL; Imhof MO
Semin Cancer Biol; 1994 Oct; 5(5):327-36. PubMed ID: 7849261
[TBL] [Abstract][Full Text] [Related]
10. New forms and future perspectives in endocrine treatment of prostatic carcinoma.
Jacobi GH; Wenderoth UK
Prog Clin Biol Res; 1984; 153():529-45. PubMed ID: 6236463
[No Abstract] [Full Text] [Related]
11. Comparative effects and mechanisms of castration, estrogen anti-androgen, and anti-estrogen-induced regression of accessory sex organ epithelium and muscle.
Neubauer B; Blume C; Cricco R; Greiner J; Mawhinney M
Invest Urol; 1981 Jan; 18(4):229-34. PubMed ID: 7451082
[TBL] [Abstract][Full Text] [Related]
12. A century of deciphering the control mechanisms of sex steroid action in breast and prostate cancer: the origins of targeted therapy and chemoprevention.
Jordan VC
Cancer Res; 2009 Feb; 69(4):1243-54. PubMed ID: 19208829
[TBL] [Abstract][Full Text] [Related]
13. Steroid hormone agonists and antagonists in the treatment of cancer.
Dreicer R; Wilding G
Cancer Invest; 1992; 10(1):27-41. PubMed ID: 1370912
[No Abstract] [Full Text] [Related]
14. [Action mechanism of sex steroid hormones].
Kato J
Nihon Rinsho; 1979 Jun; 37(6):1218-26. PubMed ID: 384049
[TBL] [Abstract][Full Text] [Related]
15. Steroid and peptide hormones and growth factors.
Howell A; Wakeling AE
Cancer Chemother Biol Response Modif; 1988; 10():117-28. PubMed ID: 3079380
[No Abstract] [Full Text] [Related]
16. Pharmacology and clinical use of sex steroid hormone receptor modulators.
Cleve A; Fritzemeier KH; Haendler B; Heinrich N; Möller C; Schwede W; Wintermantel T
Handb Exp Pharmacol; 2012; (214):543-87. PubMed ID: 23027466
[TBL] [Abstract][Full Text] [Related]
17. [Hormone treatment of prostate carcinoma: past achievements and current perspectives].
Debruyne FM
Ned Tijdschr Geneeskd; 1986 Apr; 130(17):768-71. PubMed ID: 2423888
[No Abstract] [Full Text] [Related]
18. Therapeutic uses of gonadotropin-releasing hormone analogs.
Andreyko JL; Marshall LA; Dumesic DA; Jaffe RB
Obstet Gynecol Surv; 1987 Jan; 42(1):1-21. PubMed ID: 3543765
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin releasing hormone (GnRH) analogs for the treatment of breast and prostatic carcinoma.
Santen RJ; Manni A; Harvey H
Breast Cancer Res Treat; 1986; 7(3):129-45. PubMed ID: 3096402
[TBL] [Abstract][Full Text] [Related]
20. Potential use of analogs of luteinizing hormone-releasing hormones in the treatment of hormone-sensitive neoplasms.
Schally AV; Redding TW; Comaru-Schally AM
Cancer Treat Rep; 1984 Jan; 68(1):281-9. PubMed ID: 6362868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
